Romania launches drive to vaccinate 12 to 15-year-olds

Romania has started administering COVID-19 vaccines to young teenagers aged 12 to 15, after the European Medicines Agency approved use of the Pfizer jab last week for that age group

Via AP news wire
Wednesday 02 June 2021 21:53
Virus Outbreak Romania Teenagers Vaccination
Virus Outbreak Romania Teenagers Vaccination

Romania on Wednesday started administering COVID-19 vaccines to young teenagers aged 12 to 15, after the European Medicines Agency approved use of the Pfizer jab last week for that age group in the 27-nation European Union

National vaccination committee chief Valeriu Gheorghita said more than 2,100 appointments were made for children in the past 24 hours via the online national booking platform.

Vaccination centers will also accept no-appointment walk-ins, he said, speaking at the inauguration of a children’s vaccination center in the capital, Bucharest

“By authorizing the vaccination of those between 12 to 15 years old, we bring an important advantage especially for kids with chronic diseases or other conditions which make them vulnerable to serious illness,” Gheorghita said.

Accompanied by her father, 12-year-old Alexandra Maiorescu, who is afraid of needles, got her jab from Gheorghita.

“He explained what he did step-by-step. It did not hurt as much as I expected but I was very afraid,” she told The Associated Press. “I may go to see a movie, I really was longing for that during the pandemic.”

The girl's vaccination also came as a relief for her father, Mihai Maiorescu.

“Our daughter (has) had pneumonia, and we knew that if she gets (COVID-19) she might not heal easily,” he said. “I was hoping she wouldn’t cry, and she didn’t.”

Since launching its vaccination campaign, Romania has administered nearly 8 million vaccine doses to its population of more than 19 million. But just 3.7 million people have so far been fully inoculated.

In recent weeks the number of administered daily vaccine doses in the Eastern European country has dropped, raising concerns about vaccine hesitancy in a country where COVID-19 has killed more than 30,000.

Gheorghita said Wednesday that “vaccination remains the safe and effective way to return to normality.” But he also addressed the need to extend vaccinations to rural areas where take-up lags behind urban areas.

___

Follow all of AP’s pandemic coverage at https://apnews.com/hub/coronavirus-pandemic, https://apnews.com/hub/coronavirus-vaccine and https://apnews.com/UnderstandingtheOutbreak

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in